BlackRock Health Sciences Trust (BME) Declares $0.21 Dividend

BlackRock Health Sciences Trust said on June 1, 2023 that its board of directors declared a regular monthly dividend of $0.21 per share ($2.56 annualized). Previously, the company paid $0.21 per share.

Shares must be purchased before the ex-div date of June 14, 2023 to qualify for the dividend. Shareholders of record as of June 15, 2023 will receive the payment on June 30, 2023.

At the current share price of $40.33 / share, the stock's dividend yield is 6.34%.

Looking back five years and taking a sample every week, the average dividend yield has been 5.83%, the lowest has been 4.84%, and the highest has been 8.66%. The standard deviation of yields is 0.55 (n=196).

The current dividend yield is 0.93 standard deviations above the historical average.

The company's 3-Year dividend growth rate is 0.07%, demonstrating that it has increased its dividend over time.

Learn to Harvest Dividends

Buy Stock. Capture Dividend. Sell Stock. Repeat. This is the essence of dividend harvesting and you can do it easily with Fintel's Dividend Capture Calendar.

What is the Fund Sentiment?

There are 70 funds or institutions reporting positions in BlackRock Health Sciences Trust. This is a decrease of 2 owner(s) or 2.78% in the last quarter. Average portfolio weight of all funds dedicated to BME is 0.24%, a decrease of 6.95%. Total shares owned by institutions increased in the last three months by 0.74% to 2,549K shares.

What are Other Shareholders Doing?

Nova R Wealth holds 455K shares. In it's prior filing, the firm reported owning 454K shares, representing an increase of 0.25%. The firm decreased its portfolio allocation in BME by 11.06% over the last quarter.

Wells Fargo holds 389K shares. In it's prior filing, the firm reported owning 371K shares, representing an increase of 4.67%. The firm decreased its portfolio allocation in BME by 67.60% over the last quarter.

Invesco holds 152K shares. In it's prior filing, the firm reported owning 146K shares, representing an increase of 4.06%. The firm decreased its portfolio allocation in BME by 91.17% over the last quarter.

Bank Of America holds 144K shares. In it's prior filing, the firm reported owning 146K shares, representing a decrease of 1.35%. The firm decreased its portfolio allocation in BME by 78.20% over the last quarter.

Ameriprise Financial holds 132K shares. In it's prior filing, the firm reported owning 136K shares, representing a decrease of 2.98%. The firm decreased its portfolio allocation in BME by 83.54% over the last quarter.

BlackRock Health Sciences Trust Background Information
(This description is provided by the company.)

BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield.

This story originally appeared on Fintel.